Aller au contenu Navigation Accès directs Connexion

EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY

Equipe constitutive de l'UMR1027, unité mixte INSERM - Université Toulouse III Paul Sabatier

2020

  • Camille C, Dimeglio C, Yrondi A, Compaci G, Delmas E, Gauché M, Laurent G, Birmes P. Posttraumatic Stress Disorder Symptoms in Lymphoma Patients: A Prospective Study. Front Psychiatry. 2020 Mar 11;11:201. doi: 10.3389/fpsyt.2020.00201.
     
  • Gauthier M, Conte C, Palmaro A, Patras De Campaigno E, De Barros S, Huguet F, Laurent G, Lapeyre-Mestre M, Despas F. Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population-based study in France [published online ahead of print, 2020 Feb 7]. Fundam Clin Pharmacol. 2020;10.1111/fcp.12544. doi:10.1111/fcp.12544.
     
  • Mounié M, Costa N, Conte C, Petiot D, Fabre D, Despas F, Lapeyre-Mestre M, Laurent G, Savy N, Laurent Molinier L. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France. J Med Econ. 2020;23(3):235‐242. doi:10.1080/13696998.2019.1702990.
     
  • Vayr F, Montastruc M, Savall F, Despas F, Judic E, Basso M, Dunet C, Dalenc F, Laurent G, Soulat JM, Fabrice H. Work adjustments and employment among breast cancer survivors: a French prospective study. Support Care Cancer. 2020;28(1):185–192. doi:10.1007/s00520-019-04799-w.

2019

  • Berger E, Delpierre C, Despas F, Bertoli S, Bérard E, Bombarde O, Bories P, Sarry A, Laurent G, Récher C, Lamy S. Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients. BMC Cancer. 2019 Sep 5;19(1):883. doi: 10.1186/s12885-019-6093-3.
     
  • Compaci G, Conte C, Oberic L, Ysebaert L, Laurent G, Despas F. Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey. BMC Cancer. 2019;19(1):1178. doi:10.1186/s12885-019-6337-2.
     
  • De Barros S, Vayr F, Despas F, Strumia M, Podevin C, Gauthier M, Delabesse E, Soulat JM, Laurent G, Huguet F, Herin F. The impact of chronic myeloid leukemia on employment: the French prospective study. Ann Hematol. 2019 Mar;98(3):615-623. doi: 10.1007/s00277-018-3549-5.
     
  • Jiménez Sánchez G, Maury P, Stefancikova L, Campion O, Laurent G, Chateau A, Bouraleh Hoch F, Boschetti F, Denat F, Pinel S, Devy J, Porcel E, Lacombe S, Bazzi R, Roux S. Fluorescent Radiosensitizing Gold Nanoparticles. Int J Mol Sci. 2019 Sep 18;20(18):4618. doi: 10.3390/ijms20184618.
     
  • Mounié M, Costa N, Conte C, Petiot D, Fabre D, Despas F, Lapeyre-Mestre M, Laurent G, Savy N, Molinier L. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France. J Med Econ. 2019;1–8. doi:10.1080/13696998.2019.1702990.
     
  • Lamy S, Laurent G, Lepage B, Grosclaude P, Delpierre C. Impact of comorbidity in DBLCL: direct and indirect effects on survival through unplanned chemotherapy dose reduction. J Intern Med. 2019 Apr;285(4):472-474. doi: 10.1111/joim.12879.
     
  • Walburg V, Rueter M, Lamy S, Compaci G, Lapeyre-Mestre M, Laurent G, Despas F. Fear of cancer recurrence in Non- and Hodgkin lymphoma survivors during their first three years of survivorship among French patients. Psychol Health Med. 2019 Aug;24(7):781-787. doi: 10.1080/13548506.2019.1574354.
     
  • Ysebaert L, Larcher M, Compaci G, Oberic L, Sahnes L, Banos A, Araujo C, Sommet A, Laurent G, Despas F. Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia. Ann Hematol. 2019 Apr;98(4):931-939. doi: 10.1007/s00277-019-03631-z.
     
Mise à jour novembre 2020
https://www.u1027.inserm.fr/guy-laurent-publications

Ce site utilise Google Analytics. En appuyant sur le bouton "j'accepte" ou en continuant à naviguer sur le site, vous nous autorisez à déposer des cookies à des fins de mesure d'audience.

Vous avez donné votre consentement pour le dépôt de cookies de mesures d'audience dans votre navigateur.

Vous vous êtes opposé au dépôt de cookies de mesures d'audience dans votre navigateur.

Le paramètre "Do Not Track" est actif sur votre navigateur. Aucunes statistiques de navigation ne seront collectées.